High Throughput ADME Testing
Minimizing turnaround time for ADME assays
In this episode, Matt Hutzler discusses how minimizing turnaround time for ADME assays is key to managing costs.
In this episode, Matt Hutzler discusses how minimizing turnaround time for ADME assays is key to managing costs.
In examining two-group differential analysis, it is apparent that different statistical methods can yield very different results even given the same RNA-Seq input data. In particular, we have...
With more than 25 years of experience, Rules-Based Medicine, a Q2 Solutions company develops, validates and manufactures its assays with integrity and commitment for the most reliable, reproducible...
By Chloe Ackaert, Jana Schockaert, Aurelie Mazy, Martijn Vlaming, and Sofie PattynPresented at the American Association for Cancer Research (AACR) Annual Meeting, April 5-10, 2024 Bispecifics...